NRx Pharmaceuticals, Inc. (NRXP)

NASDAQ: NRXP · Real-Time Price · USD

3.750

-0.360 (-8.76%)

At close: Jul 24, 2026, 4:00 PM EDT

3.760

+0.010 (0.27%)

After-hours: Jul 24, 2026, 7:50 PM EDT

NRx Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	157	86	32	39	74	281
Market Cap Growth	199.93%	167.90%	-16.84%	-47.66%	-73.77%	-73.19%
Enterprise Value	151.38	78.83	36.92	43.17	64.22	254.03
Last Close Price	3.75	2.71	2.20	4.60	11.10	47.80
Forward PE	-	39.16	-	-	-	-
PS Ratio	68.54	70.20	-	-	-	-
PB Ratio	-	-5.40	-1.38	-3.29	9.95	13.51
P/TBV Ratio	-	-	-	-	9.85	10.78
EV/Sales Ratio	66.02	64.35	-	-	-	-
Debt / Equity Ratio	-0.04	-0.02	-0.22	0	0.38	0.02
Net Debt / Equity Ratio	0.42	0.45	-0.21	-0.39	-1.29	-1.30
Net Debt / EBITDA Ratio	0.34	0.45	-0.26	-0.16	0.22	0.23
Net Debt / FCF Ratio	0.39	0.51	-0.45	-0.21	0.24	0.72
Asset Turnover	-	0.15	0	0	0	0
Quick Ratio	0.27	0.28	0.07	0.24	1.29	2.32
Current Ratio	0.29	0.31	0.15	0.36	1.66	2.74
Return on Equity (ROE)	164.97%	146.18%	143.76%	1394.54%	-281.79%	808.97%
Return on Assets (ROA)	-137.74%	-195.39%	-337.44%	-168.04%	-151.46%	-649.26%
Return on Capital Employed (ROCE)	118.50%	95.90%	123.57%	3706.66%	-285.69%	1033.11%
Buyback Yield / Dilution	-102.50%	-101.06%	-40.50%	-15.20%	-40.17%	-36.90%
Total Shareholder Return	-102.50%	-101.06%	-40.50%	-15.20%	-40.17%	-36.90%

SEC Filings: 10-K · 10-Q